Stay updated on Guselkumab in Active PsA: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Administrative updates were made to the study record, including an updated last update date and minor wording changes. There were no changes to the study design, eligibility criteria, primary or secondary outcomes, or enrollment.
    Difference
    0.3%
    Check dated 2025-10-28T05:11:33.000Z thumbnail image
  3. Check
    31 days ago
    Change Detected
    Summary
    - Added a prominent notice about government funding lapse and current operating status, plus a link to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed reference to v3.1.0.
    Difference
    1%
    Check dated 2025-10-06T15:58:14.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Updated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.
    Difference
    0.1%
    Check dated 2025-09-29T09:53:18.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Version bump from v3.0.1 to v3.0.2; Back to Top removed. No substantive changes to core content or key data.
    Difference
    0.1%
    Check dated 2025-09-15T00:17:13.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-07T20:43:27.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of a new facility name and location details, as well as important safety studies related to the drug guselkumab. Several previous location entries have been removed, indicating a potential focus shift in the content.
    Difference
    3%
    Check dated 2025-08-31T12:53:23.000Z thumbnail image

Stay in the know with updates to Guselkumab in Active PsA: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.